SCHEMBL21532783

SCHEMBL21532783

c1ccc(-c2nnc(-c3ccccc3)n2-c2cccc3c2c2ccccc2n3-c2ccccc2-c2ccccc2-n2c3ccccc3c3cc4c(cc32)oc2ccccc24)cc1

nearest known ligand 0.35

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 3/20 0.35
KDM4E B2RXH2 1/20 0.33
RGS12 O14924 1/20 0.33
USP2 O75604 1/20 0.33
ALDH1A1 P00352 1/20 0.33
POLB P06746 1/20 0.33
MAPT P10636 1/20 0.33
ALOX15 P16050 1/20 0.33
APOBEC3A P31941 1/20 0.33
HSD17B10 Q99714 1/20 0.33
APOBEC3G Q9HC16 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.32
HIF1A Q16665 1/20 0.32
HSD11B1 P28845 1/20 0.31
MAOA P21397 1/20 0.31
AHR P35869 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21532160 0.95 SMN1; SMN2 (0.34) AKT1KDM4ERGS12USP2ALDH1A1
SCHEMBL21532787 0.93 AKT1 (0.32) AKT1KDM4ERGS12USP2ALDH1A1
SCHEMBL21532512 0.91 AKT1 (0.36) AKT1KDM4ERGS12USP2ALDH1A1
SCHEMBL21532673 0.91 SMN1; SMN2 (0.34) AKT1KDM4ERGS12USP2ALDH1A1
SCHEMBL21532782 0.91 KDM4E (0.33) AKT1KDM4ERGS12USP2ALDH1A1
SCHEMBL21532704 0.90 KDM4E (0.33) AKT1KDM4ERGS12USP2ALDH1A1
SCHEMBL21532529 0.90 AKT1 (0.32) AKT1KDM4ERGS12USP2ALDH1A1
SCHEMBL21532567 0.89 KDM4E (0.33) AKT1KDM4ERGS12USP2ALDH1A1
SCHEMBL21532440 0.87 KDM4E (0.34) AKT1KDM4ERGS12USP2ALDH1A1
SCHEMBL21532499 0.87 ALDH1A1 (0.36) AKT1KDM4ERGS12USP2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11145825-B2 Condensed cyclic compound and organic light-emitting device including i he same SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-10-12 US disclosed
US-20190334095-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2019-10-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11145825-B2 Condensed cyclic compound and organic light-emitting device including i he same CRY1, CCNT1, CCNA1 AKT1 2105/4885KDM4E 4144/4885RGS12 3403/4885
US-20190334095-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CCNT1, ARL1 AKT1 2483/4885KDM4E 3893/4885RGS12 3191/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.